B
BMY icon

Bridgeworth’s Bristol-Myers Squibb BMY Stock Holding History

Bridgeworth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$238K Sell
4,636
-179
-4% -$9.4K 0.02% 158
2023
Q3 		$279K Hold
4,815
– – 0.03% 133
2023
Q2 		$308K Sell
4,815
-421
-8% -$28.2K 0.03% 130
2023
Q1 		$363K Sell
5,236
-64
-1% -$4.51K 0.05% 113
2022
Q4 		$381K Sell
5,300
-622
-11% -$46.9K 0.06% 104
2022
Q3 		$421K Buy
5,922
+2
+0% +$145 0.1% 92
2022
Q2 		$456K Sell
5,920
-45
-0.8% -$3.43K 0.11% 90
2022
Q1 		$436K Sell
5,965
-639
-10% -$42.9K 0.1% 88
2021
Q4 		$412K Buy
6,604
+677
+11% +$39.7K 0.09% 98
2021
Q3 		$351K Sell
5,927
-214
-3% -$14.1K 0.1% 100
2021
Q2 		$410K Buy
6,141
+1,922
+46% +$125K 0.12% 87
2021
Q1 		$266K Buy
4,219
+1
+0% +$62 0.08% 102
2020
Q4 		$262K Buy
4,218
+178
+4% +$10.9K 0.09% 100
2020
Q3 		$244K Buy
4,040
+6
+0.1% +$361 0.09% 106
2020
Q2 		$237K Sell
4,034
-3
-0.1% -$179 0.09% 107
2020
Q1 		$225K Buy
4,037
+6
+0.1% +$367 0.1% 103
2019
Q4 		$259K Buy
+4,031
New +$231K 0.1% 107
2019
Q3 		– Sell
-4,478
Closed -$203K – 132
2019
Q2 		$203K Buy
4,478
+80
+2% +$3.73K 0.08% 126
2019
Q1 		$210K Buy
+4,398
New +$219K 0.08% 126
2018
Q4 		– Sell
-4,196
Closed -$209K – 134
2018
Q3 		$209K Buy
4,196
+841
+25% +$49.9K 0.12% 119
2018
Q2 		$185K Sell
3,355
-815
-20% -$44K 0.08% 142
2018
Q1 		$259K Buy
+4,170
New +$268K 0.12% 118
2017
Q2 		– Sell
-4,255
Closed -$227K – 145
2017
Q1 		$227K Buy
4,255
+417
+11% +$22.9K 0.12% 130
2016
Q4 		$219K Buy
+3,838
New +$210K 0.12% 129

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bridgeworth's BMY Position: Q4 2023 in Review

Bridgeworth reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q4 2023, selling an estimated $9.4K and leaving 4,636 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #158.

Bridgeworth first reported a position in BMY in Q4 2016 and has held it in 24 quarters since. The position peaked at $456K in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Bridgeworth held 4,636 shares of Bristol-Myers Squibb worth $238K as of Q4 2023.
  • Bridgeworth sold 179 Bristol-Myers Squibb shares in Q4 2023, an estimated $9.4K.
  • Bristol-Myers Squibb made up 0.02% of Bridgeworth's portfolio in Q4 2023, its #158 holding.
  • Bridgeworth first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 24 quarters since.
  • Bridgeworth's Bristol-Myers Squibb position peaked at $456K in Q2 2022.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Bridgeworth's 13F filing for Q4 2023, filed 26 Jan 2024.